Journal
TRENDS IN MOLECULAR MEDICINE
Volume 17, Issue 6, Pages 313-319Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2011.01.006
Keywords
-
Funding
- Breast Cancer Research Foundation
- Donna Foundation
Ask authors/readers for more resources
Recognition that breast cancer is a heterogeneous disease in which each patient's tumor has specific characteristics has led to a search for biomarkers and combinations of markers (signatures) to improve the diagnosis, prognostic classification and prediction of therapeutic benefit versus toxicity for individual tumors and patients. Many microRNAs (miRNAs) are aberrantly expressed in cancer and seem to influence tumor behavior and progression. miRNAs have great potential to evolve into effective biomarkers in the clinic because of their extreme stability and ease of detection. However, there are several major technical challenges as well as numerous discrepancies among currently reported miRNA signatures. In this review, we discuss the use of miRNA signatures for breast cancer treatment and discuss the challenges in the field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available